Winn HR, ed. Malignant gliomas: Anaplastic astrocytoma, glioblastoma, gliosarcoma and anaplastic oligodendroglioma. In: Youmans and Winn Neurological Surgery. 8th ed. Elsevier; 2023. https://www.clinicalkey.com. Accessed May 20, 2024.
Central nervous system cancers. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1425. Accessed May 20, 2024.
Batchelor T. Initial treatment and prognosis of IDH-wildtype glioblastoma in adults. https://www.uptodate.com/contents/search. Accessed May 20, 2024.
Wen PY, et al. Glioblastoma in adults: A Society for Neuro-Oncology (SNO) and European Society of Neuro-Oncology (EANO) consensus review on current management and future directions. Neuro-Oncology. 2020; doi:10.1093/neuonc/noaa106.
Elsevier Point of Care. Clinical Overview: Brain neoplasm, glioblastoma. https://www.clinicalkey.com. Accessed May 20, 2024.
McKinnon C, et al. Glioblastoma: Clinical presentation, diagnosis, and management. BMJ. 2021; doi:10.1136/bmj.n1560.
Adult central nervous system tumors treatment (PDQ) — Health professional version. National Cancer Institute. https://www.cancer.gov/types/brain/hp/adult-brain-treatment-pdq. Accessed Feb. 10, 2026.
Distress management. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1431. Accessed May 24, 2024.
Palliative care. National Comprehensive Cancer Network. https://www.nccn.org/guidelines/guidelines-detail?category=3&id=1454. Accessed May 24, 2024.
Ghiaseddin AP, et al. Tumor treating field in the management of patients with malignant gliomas. Current Treatment Options in Oncology. 2020; doi:10.1007/s11864-020-00773-5.
Member institutions. Alliance for Clinical Trials in Oncology. https://www.allianceforclinicaltrialsinoncology.org/main/public/standard.xhtml?path=%2FPublic%2FInstitutions. Accessed May 30, 2024.